The Largest Companies by Market Capitalization, Revenues, Income and Employees within Major Pharmaceutical Preparations Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Eli Lilly And Company |
$ 686,915 |
$ 49,003 |
$ 11,106 |
43,000 |
| Johnson and Johnson |
$ 363,061 |
$ 89,331 |
$ 21,810 |
134,400 |
| Beigene Ltd |
$ 357,093 |
- |
$ 0 |
- |
| Abbvie Inc |
$ 328,352 |
$ 57,367 |
$ 4,203 |
50,000 |
| Novartis Ag |
$ 242,191 |
$ 46,660 |
$ 14,854 |
109,000 |
| Abbott Laboratories |
$ 232,363 |
$ 42,344 |
$ 13,502 |
114,000 |
| Merck and Co Inc |
$ 199,774 |
$ 63,922 |
$ 17,451 |
72,000 |
| Pfizer Inc |
$ 136,869 |
$ 62,463 |
$ 7,912 |
88,000 |
| Vertex Pharmaceuticals Inc |
$ 114,406 |
$ 11,100 |
$ -989 |
5,400 |
| Astrazeneca Plc |
$ 109,262 |
$ 45,811 |
$ 5,961 |
83,100 |
| Bristol myers Squibb Company |
$ 95,907 |
$ 47,636 |
$ 5,437 |
34,100 |
| Zoetis Inc |
$ 70,412 |
$ 9,286 |
$ 2,528 |
14,100 |
| Verona Pharma Plc |
$ 64,081 |
- |
$ -164 |
79 |
| Akari Therapeutics Plc |
$ 61,139 |
- |
$ -18 |
12 |
| Sanofi |
$ 60,117 |
$ 49,600 |
$ 6,292 |
100,000 |
| Regeneron Pharmaceuticals Inc |
$ 56,681 |
$ 14,086 |
$ 4,499 |
13,450 |
| Alnylam Pharmaceuticals Inc |
$ 40,161 |
$ 2,348 |
$ -270 |
2,100 |
| Zai Lab Limited |
$ 37,343 |
$ 418 |
$ -252 |
656 |
| Horizon Therapeutics Public Limited Company |
$ 27,190 |
$ 3,643 |
$ 438 |
1,300 |
| Takeda Pharmaceutical Company Limited |
$ 23,342 |
$ 29,167 |
$ 986 |
50,000 |
| Royalty Pharma Plc |
$ 20,153 |
$ 2,264 |
$ 1,769 |
89 |
| Teva Pharmaceutical Industries Limited |
$ 19,645 |
$ 16,617 |
$ -1,320 |
37,851 |
| Insmed Inc |
$ 18,571 |
$ 272 |
$ -1,013 |
400 |
| Summit Therapeutics Inc |
$ 15,175 |
$ 2 |
$ -241 |
105 |
| United Therapeutics Corporation |
$ 14,130 |
$ 2,994 |
$ 1,211 |
1,168 |
| Intra cellular Therapies Inc |
$ 13,677 |
$ 681 |
$ -75 |
202 |
| Hutchmed china Limited |
$ 12,953 |
$ 630 |
$ 38 |
467 |
| Karuna Therapeutics Inc |
$ 12,431 |
$ 11 |
$ -396 |
10 |
| Legend Biotech Corporation |
$ 11,987 |
$ 285 |
$ -518 |
800 |
| Catalent Inc |
$ 11,534 |
$ 4,422 |
$ -413 |
16,900 |
| Biomarin Pharmaceutical Inc |
$ 10,806 |
$ 2,950 |
$ 524 |
3,401 |
| Viatris Inc |
$ 10,577 |
$ 14,330 |
$ -3,790 |
38,000 |
| Theralink Technologies Inc |
$ 9,596 |
$ 1 |
$ -60 |
- |
| Prometheus Biosciences Inc |
$ 9,488 |
$ 4 |
$ -151 |
143 |
| Immunogen inc |
$ 8,981 |
$ 288 |
$ -74 |
346 |
| Corcept Therapeutics Inc |
$ 8,553 |
$ 685 |
$ 133 |
352 |
| Blueprint Medicines Corporation |
$ 8,529 |
$ 562 |
$ -156 |
582 |
| Roivant Sciences Ltd |
$ 8,205 |
$ 98 |
$ -357 |
750 |
| Cerevel Therapeutics Holdings Inc |
$ 8,165 |
- |
$ -460 |
260 |
| Bridgebio Pharma Inc |
$ 7,935 |
$ 127 |
$ -677 |
260 |
| Pharming Group N v |
$ 7,521 |
$ 245 |
$ -11 |
304 |
| Reata Pharmaceuticals Inc |
$ 7,154 |
$ 3 |
$ -88 |
350 |
| Elanco Animal Health Incorporated |
$ 6,718 |
$ 4,427 |
$ 373 |
9,300 |
| Jazz Pharmaceuticals Plc |
$ 6,556 |
$ 4,065 |
$ 482 |
2,800 |
| Madrigal Pharmaceuticals Inc |
$ 6,312 |
$ 317 |
$ -392 |
53 |
| Ionis Pharmaceuticals Inc |
$ 5,938 |
$ 941 |
$ -319 |
927 |
| Tg Therapeutics Inc |
$ 5,863 |
$ 386 |
$ 39 |
132 |
| Iveric Bio Inc |
$ 5,477 |
- |
$ -223 |
105 |
| Nuvalent Inc |
$ 5,371 |
$ 4 |
$ -301 |
142 |
| Biophytis Sa |
$ 5,270 |
- |
$ -19 |
20 |
| Amarin Corp Plcuk |
$ 5,184 |
$ 214 |
$ -88 |
1,650 |
| Axsome Therapeutics Inc |
$ 4,921 |
$ 449 |
$ -284 |
48 |
| Alkermes Plc |
$ 4,909 |
$ 1,514 |
$ 353 |
2,100 |
| Puretech Health Plc |
$ 4,774 |
$ 3 |
$ -67 |
118 |
| Redhill Biopharma Ltd |
$ 4,544 |
$ 7 |
$ 24 |
24 |
| Ptc Therapeutics inc |
$ 4,337 |
$ 900 |
$ 679 |
995 |
| Akero Therapeutics Inc |
$ 4,263 |
- |
$ -269 |
56 |
| Prestige Consumer Healthcare Inc |
$ 4,174 |
$ 1,137 |
$ 499 |
570 |
| Alpine Immune Sciences Inc |
$ 4,160 |
$ 57 |
$ -37 |
25 |
| Biolinerx Ltd |
$ 4,085 |
$ 5 |
$ -61 |
133 |
| Rhythm Pharmaceuticals inc |
$ 3,909 |
$ 137 |
$ -174 |
111 |
| Cytokinetics Incorporated |
$ 3,843 |
$ 19 |
$ -615 |
141 |
| Mirati Therapeutics Inc |
$ 3,815 |
$ 38 |
$ -726 |
450 |
| Acadia Pharmaceuticals Inc |
$ 3,808 |
$ 996 |
$ 229 |
598 |
| Avidity Biosciences Inc |
$ 3,788 |
$ 10 |
$ -386 |
202 |
| Structure Therapeutics Inc |
$ 3,739 |
- |
$ -143 |
93 |
| Merus N v |
$ 3,665 |
$ 55 |
$ -277 |
105 |
| Perrigo Company Plc |
$ 3,649 |
$ 4,334 |
$ -180 |
11,000 |
| Ultragenyx Pharmaceutical Inc |
$ 3,576 |
$ 591 |
$ -550 |
1,276 |
| Cymabay Therapeutics Inc |
$ 3,457 |
- |
$ -105 |
68 |
| Protagonist Therapeutics inc |
$ 3,358 |
$ 208 |
$ 56 |
112 |
| Citius Oncology Inc |
$ 3,148 |
- |
$ -6 |
- |
| Viking Therapeutics Inc |
$ 2,915 |
- |
$ -128 |
14 |
| Chinook Therapeutics Inc |
$ 2,892 |
$ 6 |
$ -246 |
79 |
| Morphic Holding inc |
$ 2,855 |
$ 75 |
$ -180 |
31 |
| Catalyst Pharmaceuticals Inc |
$ 2,854 |
$ 535 |
$ 197 |
106 |
| Crinetics Pharmaceuticals Inc |
$ 2,808 |
$ 5 |
$ -328 |
68 |
| Moonlake Immunotherapeutics |
$ 2,751 |
- |
$ -148 |
31 |
| Lyell Immunopharma Inc |
$ 2,564 |
$ 0 |
$ -335 |
154 |
| Organon and Co |
$ 2,545 |
$ 6,294 |
$ 750 |
10,000 |
| Dr Reddy s Laboratories Limited |
$ 2,534 |
$ 3,350 |
$ 668 |
22,000 |
| Amneal Pharmaceuticals Inc |
$ 2,533 |
$ 2,869 |
$ -74 |
7,700 |
| Xenon Pharmaceuticals Inc |
$ 2,522 |
$ 13 |
$ -251 |
142 |
| Mirum Pharmaceuticals Inc |
$ 2,461 |
$ 379 |
$ -77 |
90 |
| Cybin Inc |
$ 2,453 |
$ 71 |
$ -60 |
30 |
| Kazia Therapeutics Limited |
$ 2,412 |
$ 2 |
$ -27 |
17 |
| Longboard Pharmaceuticals Inc |
$ 2,336 |
- |
$ -76 |
37 |
| Can Fite Biopharma Ltd |
$ 2,296 |
$ 1 |
$ -8 |
- |
| Bausch Health Companies Inc |
$ 2,284 |
$ 9,731 |
$ -81 |
20,270 |
| Dice Therapeutics Inc |
$ 2,250 |
- |
$ -104 |
57 |
| Deciphera Pharmaceuticals Inc |
$ 2,236 |
$ 175 |
$ -190 |
355 |
| Mereo Biopharma Group Plc |
$ 2,235 |
$ 36 |
$ -47 |
36 |
| Apellis Pharmaceuticals Inc |
$ 2,219 |
$ 776 |
$ -224 |
705 |
| Metsera Inc |
$ 2,202 |
- |
$ 0 |
- |
| Ligand Pharmaceuticals Incorporated |
$ 2,189 |
$ 181 |
$ -133 |
202 |
| Kiniksa Pharmaceuticals International Plc |
$ 2,166 |
$ 481 |
$ -17 |
297 |
| Calliditas Therapeutics Ab |
$ 2,147 |
$ 129 |
$ -50 |
85 |
| Newamsterdam Pharma Company N v |
$ 2,088 |
$ 47 |
$ 0 |
150 |
| Arrowhead Pharmaceuticals Inc |
$ 2,060 |
$ 278 |
$ -155 |
211 |
| Agios Pharmaceuticals Inc |
$ 1,992 |
$ 37 |
$ 674 |
383 |
| Sarepta Therapeutics Inc |
$ 1,955 |
$ 2,233 |
$ -248 |
1,314 |
| Immutep Limited |
$ 1,920 |
$ 8 |
$ -43 |
40 |
| Ideaya Biosciences Inc |
$ 1,915 |
$ 50 |
$ -307 |
104 |
| Harmony Biosciences Holdings inc |
$ 1,866 |
$ 744 |
$ 153 |
246 |
| Belite Bio Inc |
$ 1,847 |
- |
$ -36 |
60 |
| Galapagos Nv |
$ 1,807 |
$ 268 |
$ 237 |
588 |
| Supernus Pharmaceuticals inc |
$ 1,803 |
$ 668 |
$ 62 |
652 |
| Nektar Therapeutics |
$ 1,795 |
$ 87 |
$ -133 |
711 |
| Indivior Plc |
$ 1,751 |
$ 1,093 |
$ 2 |
1,152 |
| Arcutis Biotherapeutics Inc |
$ 1,742 |
$ 213 |
$ -1 |
92 |
| Amicus Therapeutics inc |
$ 1,735 |
$ 542 |
$ -29 |
1,246 |
| Disc Medicine Inc |
$ 1,720 |
- |
$ -116 |
60 |
| Centessa Pharmaceuticals Plc |
$ 1,654 |
- |
$ -224 |
401 |
| Taro Pharmaceutical Industries Ltd |
$ 1,615 |
$ 573 |
$ 25 |
4,300 |
| Rapt Therapeutics Inc |
$ 1,600 |
$ 3 |
$ -117 |
42 |
| Ars Pharmaceuticals Inc |
$ 1,580 |
- |
$ 8 |
31 |
| Schrodinger Inc |
$ 1,495 |
$ 231 |
$ -192 |
378 |
| 89bio Inc |
$ 1,475 |
- |
$ -387 |
19 |
| Biohaven Ltd |
$ 1,474 |
$ 860 |
$ -889 |
239 |
| Janux Therapeutics Inc |
$ 1,458 |
$ 13 |
$ -78 |
37 |
| Ocular Therapeutix Inc |
$ 1,377 |
$ 60 |
$ -193 |
103 |
| Edgewise Therapeutics inc |
$ 1,360 |
- |
$ -146 |
21 |
| Vera Therapeutics Inc |
$ 1,328 |
- |
$ -175 |
34 |
| Point Biopharma Global Inc |
$ 1,322 |
$ 244 |
$ 97 |
100 |
| Innoviva Inc |
$ 1,317 |
$ 408 |
$ -60 |
648 |
| Ani Pharmaceuticals Inc |
$ 1,314 |
$ 674 |
$ -21 |
642 |
| Travere Therapeutics Inc |
$ 1,264 |
$ 274 |
$ -227 |
380 |
| Dynavax Technologies Corporation |
$ 1,247 |
$ 295 |
$ -60 |
275 |
| Amphastar Pharmaceuticals Inc |
$ 1,225 |
$ 722 |
$ 136 |
1,761 |
| Aspire Biopharma Holdings Inc |
$ 1,212 |
- |
$ 0 |
- |
| Mannkind Corporation |
$ 1,210 |
$ 298 |
$ 30 |
202 |
| Curevac N v |
$ 1,201 |
$ 60 |
$ -291 |
370 |
| Cti Biopharma Corp |
$ 1,196 |
$ 76 |
$ -69 |
80 |
| Dyne Therapeutics Inc |
$ 1,134 |
- |
$ -367 |
61 |
| Eqrx Inc |
$ 1,133 |
- |
$ -260 |
250 |
| Pacira Biosciences inc |
$ 1,127 |
$ 703 |
$ -104 |
1,243 |
| Liquidia Corporation |
$ 1,122 |
$ 14 |
$ -128 |
82 |
| Aurinia Pharmaceuticals Inc |
$ 1,113 |
$ 247 |
$ 40 |
48 |
| Harrow Inc |
$ 1,094 |
$ 199 |
$ -17 |
382 |
| Wave Life Sciences Ltd |
$ 1,068 |
$ 105 |
$ -112 |
288 |
| Enliven Therapeutics Inc |
$ 1,066 |
- |
$ -95 |
20 |
| Abcellera Biologics Inc |
$ 1,015 |
$ 23 |
$ -168 |
220 |
| Geron Corp |
$ 1,006 |
$ 116 |
$ -139 |
18 |
| Collegium Pharmaceutical inc |
$ 980 |
$ 498 |
$ 44 |
337 |
| Phibro Animal Health Corporation |
$ 972 |
$ 1,190 |
$ 32 |
1,940 |
| Rayzebio Inc |
$ 962 |
- |
$ 0 |
52 |
| Nurix Therapeutics Inc |
$ 960 |
$ 56 |
$ -208 |
117 |
| Zymeworks Inc |
$ 939 |
$ 93 |
$ -114 |
955 |
| Verve Therapeutics Inc |
$ 935 |
$ 32 |
$ -199 |
21 |
| Praxis Precision Medicines Inc |
$ 892 |
$ 9 |
$ -213 |
82 |
| Akebia Therapeutics Inc |
$ 889 |
$ 185 |
$ -45 |
410 |
| Avadel Pharmaceuticals Plc |
$ 887 |
$ 194 |
$ -26 |
154 |
| Opko Health Inc |
$ 866 |
$ 689 |
$ -39 |
3,930 |
| Arrivent Biopharma inc |
$ 855 |
- |
$ -127 |
52 |
| Ardelyx inc |
$ 850 |
$ 362 |
$ -54 |
52 |
| Arcus Biosciences Inc |
$ 848 |
$ 141 |
$ -391 |
21,164 |
| Silence Therapeutics Plc |
$ 843 |
$ 25 |
$ -43 |
116 |
| Gyre Therapeutics Inc |
$ 823 |
$ 101 |
$ 12 |
18 |
| Cogent Biosciences Inc |
$ 819 |
$ 8 |
$ -269 |
102 |
| Syndax Pharmaceuticals Inc |
$ 817 |
$ 44 |
$ -331 |
56 |
| Cormedix Inc |
$ 813 |
$ 0 |
$ -18 |
25 |
| Avid Bioservices Inc |
$ 797 |
$ 151 |
$ -152 |
371 |
| Intercept Pharmaceuticals inc |
$ 794 |
$ 288 |
$ -62 |
375 |
| Elite Pharmaceuticals Inc |
$ 793 |
$ 70 |
$ -18 |
64 |
| Unicycive Therapeutics Inc |
$ 785 |
- |
$ -15 |
11 |
| Chimerix Inc |
$ 763 |
$ 33 |
$ -88 |
201 |
| Uniqure N v |
$ 755 |
$ 20 |
$ -218 |
80 |
| Phathom Pharmaceuticals Inc |
$ 750 |
$ 82 |
$ -346 |
55 |
| Mineralys Therapeutics Inc |
$ 717 |
- |
$ -189 |
23 |
| Anaptysbio inc |
$ 710 |
$ 112 |
$ -141 |
49 |
| Trevi Therapeutics Inc |
$ 701 |
- |
$ -47 |
26 |
| Urogen Pharma Ltd |
$ 695 |
$ 91 |
$ -138 |
201 |
| Stoke Therapeutics Inc |
$ 688 |
$ 191 |
$ 50 |
128 |
| Xeris Biopharma Holdings Inc |
$ 688 |
$ 223 |
$ 36 |
65 |
| Nuvation Bio Inc |
$ 667 |
$ 11 |
$ -606 |
43 |
| Evotec Se |
$ 665 |
$ 875 |
$ -94 |
2,200 |
| Oric Pharmaceuticals Inc |
$ 661 |
- |
$ -133 |
74 |
| Arbutus Biopharma Corp |
$ 654 |
$ 6 |
$ -146 |
57 |
| Morphosys Ag |
$ 651 |
$ 267 |
$ -213 |
511 |
| Day One Biopharmaceuticals Inc |
$ 649 |
$ 162 |
$ -79 |
49 |
| Sinovac Biotech Ltd |
$ 644 |
$ 448 |
$ -258 |
1,000 |
| Gh Research Plc |
$ 644 |
- |
$ -36 |
- |
| Kalvista Pharmaceuticals Inc |
$ 640 |
$ 13 |
$ -176 |
45 |
| Addex Therapeutics Ltd |
$ 638 |
$ 2 |
$ -11 |
17 |
| Xencor Inc |
$ 629 |
$ 127 |
$ -211 |
280 |
| Dianthus Therapeutics Inc |
$ 603 |
$ 7 |
$ -101 |
19 |
| Evolus Inc |
$ 591 |
$ 380 |
$ -56 |
130 |
| Upstream Bio Inc |
$ 583 |
- |
$ 0 |
- |
| Fibrogen Inc |
$ 580 |
$ 180 |
$ -10 |
333 |
| Oculis Holding Ag |
$ 576 |
$ 1 |
$ -89 |
- |
| Sage Therapeutics Inc |
$ 575 |
$ 47 |
$ -354 |
353 |
| Tango Therapeutics Inc |
$ 569 |
$ 41 |
$ -132 |
78 |
| Benitec Biopharma Inc |
$ 564 |
$ 0 |
$ -27 |
16 |
| Keros Therapeutics Inc |
$ 553 |
$ 239 |
$ 4 |
92 |
| Thorne Healthtech Inc |
$ 549 |
$ 256 |
$ 20 |
202 |
| Tyra Biosciences Inc |
$ 548 |
- |
$ -96 |
60 |
| Arvinas Inc |
$ 541 |
$ 427 |
$ -47 |
202 |
| Altimmune inc |
$ 531 |
$ 0 |
$ -90 |
59 |
| Theravance Biopharma inc |
$ 528 |
$ 65 |
$ -58 |
202 |
| Regulus Therapeutics Inc |
$ 521 |
$ 0 |
$ -48 |
34 |
| Xtl Biopharmaceuticals Ltd |
$ 518 |
- |
$ -1 |
14 |
| Bicycle Therapeutics Plc |
$ 513 |
$ 26 |
$ -203 |
61 |
| Kura Oncology Inc |
$ 511 |
- |
$ -182 |
89 |
| Bicara Therapeutics Inc |
$ 508 |
- |
$ 0 |
55 |
| Zevra Therapeutics Inc |
$ 489 |
$ 41 |
$ -92 |
23 |
| I mab |
$ 467 |
$ 4 |
$ -22 |
- |
| Septerna Inc |
$ 460 |
- |
$ 0 |
- |
| Compass Pathways Plc |
$ 457 |
- |
$ -138 |
76 |
| Immunome Inc |
$ 451 |
$ 13 |
$ -158 |
35 |
| Savara Inc |
$ 445 |
- |
$ -102 |
25 |
| Siga Technologies Inc |
$ 437 |
$ 120 |
$ 49 |
46 |
| Fulcrum Therapeutics Inc |
$ 437 |
$ 11 |
$ -1 |
80 |
| Amylyx Pharmaceuticals Inc |
$ 433 |
$ 196 |
$ -219 |
113 |
| Chemomab Therapeutics Ltd |
$ 431 |
- |
$ 14 |
40 |
| Xoma Royalty Corporation |
$ 428 |
$ 43 |
$ -10 |
13 |
| Precigen Inc |
$ 426 |
- |
$ -157 |
99 |
| Organogenesis Holdings Inc |
$ 408 |
$ 459 |
$ -20 |
862 |
| Atai Life Sciences N v |
$ 398 |
$ 0 |
$ -150 |
202 |
| Kamada Ltd |
$ 398 |
$ 143 |
$ 8 |
572 |
| Heron Therapeutics Inc |
$ 394 |
$ 148 |
$ -8 |
328 |
| Erasca Inc |
$ 388 |
- |
$ -158 |
103 |
| Rapport Therapeutics Inc |
$ 385 |
- |
$ -24 |
- |
| Zenas Biopharma Inc |
$ 384 |
- |
$ 0 |
130 |
| Cytodyn inc |
$ 381 |
- |
$ -7 |
23 |
| Revance Therapeutics Inc |
$ 380 |
$ 247 |
$ -2 |
534 |
| Capricor Therapeutics inc |
$ 377 |
$ 22 |
$ -55 |
11 |
| G1 Therapeutics Inc |
$ 375 |
$ 58 |
$ -45 |
55 |
| Neurogene Inc |
$ 373 |
- |
$ -81 |
81 |
| Eton Pharmaceuticals Inc |
$ 365 |
$ 48 |
$ -5 |
31 |
| Terns Pharmaceuticals Inc |
$ 357 |
- |
$ -90 |
59 |
| Emergent Biosolutions Inc |
$ 356 |
$ 965 |
$ -132 |
1,600 |
| Olema Pharmaceuticals Inc |
$ 353 |
- |
$ -129 |
45 |
| Annexon Inc |
$ 352 |
- |
$ -167 |
71 |
| Rigel Pharmaceuticals Inc |
$ 344 |
$ 203 |
$ 37 |
135 |
| Astria Therapeutics Inc |
$ 340 |
- |
$ -108 |
14 |
| Arcturus Therapeutics Holdings Inc |
$ 333 |
$ 144 |
$ -68 |
180 |
| Gossamer Bio Inc |
$ 327 |
$ 125 |
$ -51 |
74 |
| Mbx Biosciences Inc |
$ 325 |
- |
$ 0 |
- |
| Cryoport inc |
$ 318 |
$ 215 |
$ -116 |
31 |
| Aquestive Therapeutics Inc |
$ 310 |
$ 54 |
$ -54 |
67 |
| Prothena Corporation Public Limited Company |
$ 308 |
$ 138 |
$ -110 |
173 |
| Alimera Sciences Inc |
$ 301 |
$ 98 |
$ -15 |
159 |
| Corvus Pharmaceuticals Inc |
$ 298 |
- |
$ -41 |
31 |
| Rocket Pharmaceuticals Inc |
$ 297 |
- |
$ -258 |
143 |
| Adc Therapeutics Sa |
$ 297 |
$ 76 |
$ -150 |
174 |
| Foghorn Therapeutics Inc |
$ 297 |
$ 24 |
$ -80 |
54 |
| Maravai Lifesciences Holdings Inc |
$ 295 |
$ 242 |
$ -290 |
1,338 |
| Entrada Therapeutics Inc |
$ 292 |
$ 172 |
$ 49 |
75 |
| Rezolute Inc |
$ 288 |
- |
$ -73 |
42 |
| Sagimet Biosciences inc |
$ 281 |
- |
$ -57 |
111 |
| Atea Pharmaceuticals Inc |
$ 277 |
- |
$ -170 |
10 |
| Nature s Sunshine Products inc |
$ 276 |
$ 455 |
$ 10 |
819 |
| Lexicon Pharmaceuticals Inc |
$ 272 |
$ 31 |
$ -177 |
285 |
| 2seventy Bio Inc |
$ 267 |
$ 48 |
$ -4 |
202 |
| Verastem Inc |
$ 267 |
$ 4 |
$ -149 |
80 |
| Vanda Pharmaceuticals Inc |
$ 264 |
$ 201 |
$ -44 |
500 |
| Abivax Sa |
$ 257 |
- |
$ -165 |
43 |
| Lifecore Biomedical Inc |
$ 257 |
$ 131 |
$ -49 |
209 |
| Checkpoint Therapeutics inc |
$ 255 |
$ 0 |
$ -57 |
19 |
| Cartesian Therapeutics Inc |
$ 253 |
$ 40 |
$ -43 |
66 |
| Inozyme Pharma Inc |
$ 251 |
- |
$ -102 |
67 |
| Third Harmonic Bio Inc |
$ 245 |
- |
$ 53 |
53 |
| Palvella Therapeutics Inc |
$ 243 |
- |
$ 0 |
- |
| Abeona Therapeutics Inc |
$ 242 |
$ 4 |
$ -64 |
30 |
| Aslan Pharmaceuticals Limited |
$ 241 |
$ 12 |
$ -44 |
- |
| Monopar Therapeutics Inc |
$ 230 |
- |
$ -17 |
22 |
| Acelyrin Inc |
$ 229 |
- |
$ -269 |
202 |
| Bolt Biotherapeutics Inc |
$ 222 |
$ 4 |
$ -63 |
21 |
| Merrimack Pharmaceuticals Inc |
$ 219 |
- |
$ -3 |
117 |
| Design Therapeutics Inc |
$ 212 |
- |
$ -56 |
54 |
| Tenax Therapeutics Inc |
$ 212 |
- |
$ 3 |
10 |
| Esperion Therapeutics Inc |
$ 210 |
$ 260 |
$ -153 |
72 |
| Spectrum Pharmaceuticals Inc |
$ 208 |
$ 109 |
$ -65 |
146 |
| Scpharmaceuticals Inc |
$ 206 |
$ 42 |
$ -91 |
4,375 |
| Hcw Biologics Inc |
$ 204 |
$ 1 |
$ -25 |
- |
| Cytomx Therapeutics Inc |
$ 202 |
$ 148 |
$ 42 |
120 |
| Sol gel Technologies Ltd |
$ 201 |
$ 12 |
$ -11 |
20 |
| Y mabs Therapeutics inc |
$ 199 |
$ 89 |
$ -28 |
100 |
| Sensei Biotherapeutics Inc |
$ 193 |
- |
$ -29 |
14 |
| Tonix Pharmaceuticals Holding Corp |
$ 192 |
$ 10 |
$ -132 |
70 |
| Omeros Corporation |
$ 186 |
- |
$ -153 |
50 |
| Aldeyra Therapeutics Inc |
$ 183 |
- |
$ -58 |
201 |
| Theseus Pharmaceuticals Inc |
$ 178 |
- |
$ -57 |
34 |
| Aclaris Therapeutics Inc |
$ 177 |
$ 18 |
$ -130 |
91 |
| Spero Therapeutics Inc |
$ 167 |
$ 45 |
$ -70 |
75 |
| Lifevantage Corp |
$ 167 |
$ 222 |
$ 9 |
222 |
| Larimar Therapeutics Inc |
$ 166 |
- |
$ -95 |
65 |
| Nanobiotix S a |
$ 164 |
$ 41 |
$ -44 |
81 |
| Tiziana Life Sciences Ltd |
$ 162 |
- |
$ -18 |
16 |
| Ventyx Biosciences Inc |
$ 161 |
- |
$ -124 |
79 |
| Puma Biotechnology Inc |
$ 159 |
$ 233 |
$ 38 |
460 |
| Ac Immune Sa |
$ 159 |
$ 15 |
$ -54 |
83 |
| Bioage Labs Inc |
$ 156 |
$ 2 |
$ -124 |
10 |
| Alumis inc |
$ 155 |
- |
$ 0 |
- |
| Diamedica Therapeutics Inc |
$ 155 |
- |
$ -27 |
28 |
| Enanta Pharmaceuticals Inc |
$ 153 |
$ 64 |
$ -96 |
131 |
| Galectin Therapeutics Inc |
$ 153 |
- |
$ -42 |
20 |
| Inventiva S a |
$ 149 |
$ 46 |
$ -124 |
90 |
| Journey Medical Corp |
$ 147 |
$ 56 |
$ -8 |
19 |
| Alt5 Sigma Corporation |
$ 147 |
$ 17 |
$ -7 |
- |
| Aardvark Therapeutics Inc |
$ 147 |
- |
$ 0 |
- |
| Eupraxia Pharmaceuticals Inc |
$ 147 |
- |
$ -26 |
- |
| Actuate Therapeutics Inc |
$ 146 |
- |
$ -6 |
16 |
| Landos Biopharma Inc |
$ 144 |
- |
$ 20 |
27 |
| Nuvectis Pharma inc |
$ 139 |
- |
$ -19 |
13 |
| Sellas Life Sciences Group Inc |
$ 135 |
- |
$ -27 |
15 |
| Eledon Pharmaceuticals Inc |
$ 131 |
- |
$ -36 |
10 |
| Nkarta Inc |
$ 131 |
- |
$ -111 |
157 |
| Assembly Biosciences Inc |
$ 131 |
$ 32 |
$ -40 |
73 |
| Pardes Biosciences Inc |
$ 130 |
- |
$ -76 |
34 |
| Beyondspring Inc |
$ 128 |
$ 1 |
$ -36 |
- |
| Paratek Pharmaceuticals Inc |
$ 127 |
$ 167 |
$ -66 |
71 |
| Ngm Biopharmaceuticals Inc |
$ 127 |
$ 4 |
$ -142 |
100 |
| Kinnate Biopharma Inc |
$ 125 |
- |
$ -127 |
99 |
| Contineum Therapeutics Inc |
$ 123 |
- |
$ -50 |
10 |
| Decibel Therapeutics Inc |
$ 123 |
- |
$ -63 |
40 |
| Greenwich Lifesciences Inc |
$ 117 |
- |
$ -10 |
10 |
| Korro Bio Inc |
$ 116 |
- |
$ -87 |
72 |
| Milestone Pharmaceuticals Inc |
$ 113 |
- |
$ -52 |
33 |
| Ironwood Pharmaceuticals inc |
$ 113 |
$ 318 |
$ -32 |
412 |
| Optinose Inc |
$ 112 |
$ 91 |
$ -30 |
201 |
| Tuhura Biosciences Inc |
$ 111 |
- |
$ 0 |
- |
| Anixa Biosciences Inc |
$ 109 |
- |
$ -13 |
14 |
| Cyteir Therapeutics Inc |
$ 109 |
$ 1,545 |
$ -33 |
98 |
| Portage Biotech Inc |
$ 108 |
- |
$ -75 |
11 |
| Adagene Inc |
$ 107 |
$ 0 |
$ -33 |
77 |
| Lakeshore Biopharma Co Ltd |
$ 105 |
$ 81 |
$ -61 |
- |
| Rain Oncology Inc |
$ 105 |
- |
$ -72 |
48 |
| Elicio Therapeutics Inc |
$ 104 |
$ 30 |
$ -51 |
32 |
| Societal Cdmo Inc |
$ 103 |
$ 95 |
$ -13 |
300 |
| Vtv Therapeutics Inc |
$ 102 |
$ 5 |
$ -23 |
57 |
| Atossa Therapeutics Inc |
$ 102 |
- |
$ -26 |
10 |
| Bright Minds Biosciences Inc |
$ 102 |
- |
$ -6 |
57 |
| Corbus Pharmaceuticals Holdings Inc |
$ 101 |
$ 2 |
$ -50 |
52 |
| Organigram Holdings Inc |
$ 100 |
$ 112 |
$ -11 |
800 |
| Arca Biopharma Inc |
$ 100 |
- |
$ -54 |
24 |
| Cassava Sciences Inc |
$ 96 |
- |
$ -73 |
29 |
| Bgm Group Ltd |
$ 94 |
$ 24 |
$ -2 |
- |
| Genelux Corporation |
$ 93 |
- |
$ -31 |
- |
| Zentalis Pharmaceuticals Inc |
$ 93 |
- |
$ -224 |
166 |
| Coya Therapeutics Inc |
$ 92 |
- |
$ -17 |
42 |
| Nls Pharmaceutics Ltd |
$ 92 |
- |
$ -12 |
25 |
| Veru Inc |
$ 91 |
$ 17 |
$ 1 |
89 |
| Immuneering Corporation |
$ 91 |
$ 0 |
$ -62 |
13 |
| Oramed Pharmaceuticals Inc |
$ 88 |
$ 3 |
$ -28 |
16 |
| Skye Bioscience Inc |
$ 86 |
- |
$ -33 |
10 |
| Io Biotech Inc |
$ 86 |
- |
$ -98 |
19 |
| Whitehawk Therapeutics Inc |
$ 83 |
- |
$ 0 |
- |
| Macrogenics Inc |
$ 82 |
$ 154 |
$ -56 |
341 |
| Pliant Therapeutics Inc |
$ 78 |
$ 10 |
$ -220 |
26 |
| Aerovate Therapeutics inc |
$ 78 |
- |
$ -59 |
10 |
| Neonc Technologies Holdings Inc |
$ 77 |
- |
$ 0 |
- |
| Essa Pharma inc |
$ 77 |
$ 1 |
$ -28 |
18 |
| Xbiotech Inc |
$ 76 |
$ 8 |
$ -39 |
32 |
| Inovio Pharmaceuticals Inc |
$ 76 |
$ 8 |
$ -96 |
134 |
| Immunic Inc |
$ 73 |
- |
$ -96 |
21 |
| Igm Biosciences Inc |
$ 72 |
- |
$ -199 |
224 |
| Pyxis Oncology Inc |
$ 71 |
- |
$ -95 |
10 |
| Renovorx Inc |
$ 70 |
- |
$ 0 |
- |
| Intercure Ltd |
$ 69 |
$ 356 |
$ -64 |
450 |
| Cumberland Pharmaceuticals Inc |
$ 66 |
$ 41 |
$ -3 |
91 |
| Biomea Fusion Inc |
$ 66 |
- |
$ -138 |
80 |
| Pds Biotechnology Corp |
$ 66 |
- |
$ -35 |
24 |
| Prelude Therapeutics Inc |
$ 65 |
- |
$ -128 |
17 |
| Zynerba Pharmaceuticals Inc |
$ 65 |
- |
$ -38 |
12 |
| China Health Industries Holdings Inc |
$ 65 |
$ 0 |
$ -1 |
- |
| Clearside Biomedical Inc |
$ 65 |
$ 4 |
$ -31 |
32 |
| Seres Therapeutics Inc |
$ 64 |
$ 13 |
$ 73 |
100 |
| Adlai Nortye Ltd |
$ 64 |
$ 5 |
$ -105 |
50 |
| Immix Biopharma Inc |
$ 64 |
- |
$ -22 |
21 |
| Viveon Health Acquisition Corp |
$ 63 |
- |
$ 1 |
11 |
| Medicinova Inc |
$ 63 |
- |
$ -11 |
13 |
| Vistagen Therapeutics Inc |
$ 62 |
$ 0 |
$ -51 |
39 |
| Adicet Bio Inc |
$ 61 |
$ 39 |
$ -117 |
50 |
| Alto Neuroscience Inc |
$ 61 |
- |
$ -63 |
- |
| Assertio Holdings inc |
$ 60 |
$ 119 |
$ -31 |
300 |
| Repare Therapeutics Inc |
$ 60 |
$ 69 |
$ -128 |
179 |
| Cervomed Inc |
$ 60 |
$ 9 |
$ -19 |
79 |
| Climb Bio Inc |
$ 58 |
- |
$ -74 |
- |
| Connect Biopharma Holdings Limited |
$ 57 |
- |
$ -60 |
99 |
| Pmv Pharmaceuticals Inc |
$ 57 |
- |
$ -61 |
47 |
| Sigilon Therapeutics Inc |
$ 56 |
$ 18 |
$ -30 |
22 |
| Renovaro Inc |
$ 56 |
- |
$ -67 |
- |
| Verrica Pharmaceuticals Inc |
$ 55 |
$ 7 |
$ -66 |
35 |
| Context Therapeutics Inc |
$ 55 |
- |
$ -28 |
13 |
| Kronos Bio Inc |
$ 54 |
$ 9 |
$ -64 |
74 |
| Werewolf Therapeutics Inc |
$ 53 |
$ 16 |
$ -72 |
18 |
| Serina Therapeutics Inc |
$ 52 |
$ 0 |
$ -16 |
- |
| Cue Biopharma Inc |
$ 52 |
$ 8 |
$ -41 |
89 |
| Maia Biotechnology Inc |
$ 52 |
- |
$ -20 |
13 |
| Xilio Therapeutics inc |
$ 51 |
$ 9 |
$ -54 |
64 |
| Gain Therapeutics inc |
$ 51 |
$ 0 |
$ -21 |
18 |
| Applied Therapeutics Inc |
$ 50 |
$ 0 |
$ -44 |
80 |
| Avalo Therapeutics Inc |
$ 49 |
$ 17 |
$ 73 |
44 |
| Shattuck Labs Inc |
$ 49 |
$ 6 |
$ -71 |
202 |
| Pepgen Inc |
$ 47 |
- |
$ -102 |
22 |
| Fortress Biotech Inc |
$ 47 |
$ 58 |
$ -107 |
101 |
| Oncolytics Biotech Inc |
$ 47 |
- |
$ -21 |
37 |
| Mersana Therapeutics inc |
$ 46 |
$ 34 |
$ -74 |
102 |
| Earth Science Tech Inc |
$ 45 |
$ 31 |
$ 2 |
- |
| Annovis Bio Inc |
$ 45 |
- |
$ -29 |
812 |
| Acrivon Therapeutics Inc |
$ 45 |
- |
$ -84 |
43 |
| Actinium Pharmaceuticals Inc |
$ 45 |
$ 1 |
$ -38 |
37 |
| Inflarx N v |
$ 44 |
$ 0 |
$ -48 |
50 |
| Forte Biosciences Inc |
$ 43 |
- |
$ -35 |
14 |
| Anebulo Pharmaceuticals Inc |
$ 42 |
- |
$ -8 |
10 |
| Mural Oncology Plc |
$ 42 |
- |
$ -131 |
33 |
| Rapid Therapeutic Science Laboratories Inc |
$ 42 |
- |
$ 0 |
3 |
| Zomedica Corp |
$ 41 |
$ 27 |
$ -102 |
- |
| Rafael Holdings Inc |
$ 40 |
$ 1 |
$ -79 |
18 |
| Tvardi Therapeutics inc |
$ 39 |
- |
$ 0 |
- |
| Celularity Inc |
$ 39 |
$ 48 |
$ -35 |
202 |
| Vyne Therapeutics Inc |
$ 38 |
$ 1 |
$ -42 |
30 |
| Os Therapies Incoporated |
$ 38 |
- |
$ -13 |
- |
| Clene Inc |
$ 38 |
$ 0 |
$ -29 |
76 |
| Karyopharm Therapeutics Inc |
$ 37 |
$ 142 |
$ -63 |
325 |
| Transcode Therapeutics Inc |
$ 37 |
- |
$ -26 |
10 |
| Satsuma Pharmaceuticals Inc |
$ 36 |
- |
$ -65 |
33 |
| Scynexis Inc |
$ 36 |
$ 3 |
$ -27 |
99 |
| Lumos Pharma Inc |
$ 36 |
$ 2 |
$ -35 |
23 |
| Provectus Biopharmaceuticals Inc |
$ 35 |
$ 1 |
$ -5 |
23 |
| Lava Therapeutics Nv |
$ 35 |
- |
$ 0 |
- |
| Jupiter Neurosciences Inc |
$ 34 |
- |
$ 0 |
- |
| Lantern Pharma Inc |
$ 34 |
- |
$ -21 |
22 |
| Lianbio |
$ 34 |
- |
$ -1 |
129 |
| Reviva Pharmaceuticals Holdings Inc |
$ 34 |
- |
$ -29 |
12 |
| Hst Global Inc |
$ 34 |
- |
$ 0 |
- |
| Barinthus Biotherapeutics Plc |
$ 34 |
- |
$ -65 |
- |
| Rein Therapeutics Inc |
$ 34 |
- |
$ 0 |
- |
| Iterum Therapeutics Plc |
$ 34 |
$ 14 |
$ -23 |
18 |
| Eterna Therapeutics Inc |
$ 33 |
$ 1 |
$ -45 |
31 |
| An2 Therapeutics Inc |
$ 33 |
$ 1 |
$ -45 |
22 |
| Kezar Life Sciences Inc |
$ 33 |
- |
$ -79 |
55 |
| Opus Genetics Inc |
$ 32 |
- |
$ 0 |
- |
| Onkure Therapeutics Inc |
$ 32 |
- |
$ -60 |
10 |
| Eagle Pharmaceuticals inc |
$ 32 |
$ 258 |
$ 12 |
117 |
| Marinus Pharmaceuticals Inc |
$ 31 |
$ 32 |
$ -132 |
165 |
| Psyence Biomedical ltd |
$ 31 |
$ 0 |
$ -51 |
65 |
| Rockwell Medical inc |
$ 30 |
$ 97 |
$ 0 |
56 |
| Allakos Inc |
$ 30 |
- |
$ -71 |
131 |
| Nrx Pharmaceuticals Inc |
$ 29 |
- |
$ -25 |
20 |
| Intelgenx Technologies Corp |
$ 29 |
$ 1 |
$ -11 |
30 |
| Camp4 Therapeutics Corporation |
$ 28 |
$ 285 |
$ -149 |
333 |
| Aeterna Zentaris Inc |
$ 28 |
$ 5 |
$ -17 |
35 |
| Abvc Biopharma Inc |
$ 28 |
$ 1 |
$ -6 |
29 |
| Pulmatrix Inc |
$ 27 |
$ 8 |
$ -10 |
13 |
| Alx Oncology Holdings Inc |
$ 26 |
- |
$ -130 |
20 |
| Immunoprecise Antibodies Ltd |
$ 26 |
$ 19 |
$ -21 |
142 |
| Kala Bio inc |
$ 26 |
$ 6 |
$ -36 |
38 |
| Generation Bio Co |
$ 25 |
$ 25 |
$ -72 |
115 |
| Dar Bioscience Inc |
$ 25 |
$ 0 |
$ 0 |
23 |
| Oragenics Inc |
$ 24 |
$ 0 |
$ -11 |
12 |
| Medicus Pharma Ltd |
$ 24 |
- |
$ 0 |
- |
| Igc Pharma Inc |
$ 23 |
$ 1 |
$ -12 |
15 |
| Tempest Therapeutics Inc |
$ 23 |
- |
$ -45 |
18 |
| Mainz Biomed N v |
$ 23 |
$ 1 |
$ -26 |
120 |
| Boundless Bio Inc |
$ 23 |
- |
$ -66 |
47 |
| Calcimedica Inc |
$ 23 |
- |
$ -19 |
- |
| Nanoviricides inc |
$ 23 |
- |
$ -10 |
11 |
| Fibrobiologics Inc |
$ 23 |
- |
$ -11 |
11 |
| Durect Corp |
$ 21 |
$ 9 |
$ -5 |
61 |
| Lisata Therapeutics Inc |
$ 21 |
- |
$ -19 |
25 |
| Relmada Therapeutics Inc |
$ 21 |
- |
$ -76 |
17 |
| Casi Pharmaceuticals inc |
$ 20 |
$ 29 |
$ -39 |
100 |
| Enlivex Therapeutics Ltd |
$ 20 |
- |
$ -29 |
29 |
| Ayala Pharmaceuticals Inc |
$ 20 |
$ 4 |
$ -18 |
11 |
| Lipocine Inc |
$ 19 |
$ 14 |
$ 4 |
16 |
| Oncotelic Therapeutics Inc |
$ 19 |
- |
$ -5 |
8 |
| Artelo Biosciences Inc |
$ 19 |
- |
$ -10 |
11 |
| Q32 Bio Inc |
$ 19 |
$ 3 |
$ -60 |
42 |
| Mira Pharmaceuticals Inc |
$ 19 |
- |
$ -8 |
- |
| Carisma Therapeutics Inc |
$ 18 |
$ 20 |
$ -41 |
46 |
| Longeveron Inc |
$ 18 |
$ 2 |
$ -26 |
23 |
| Promis Neurosciences inc |
$ 17 |
- |
$ -1 |
18 |
| Protagenic Therapeutics Inc new |
$ 17 |
- |
$ -6 |
10 |
| Lexaria Bioscience Corp |
$ 17 |
$ 1 |
$ -9 |
27 |
| Alzamend Neuro Inc |
$ 17 |
- |
$ -4 |
10 |
| Rani Therapeutics Holdings Inc |
$ 17 |
- |
$ -55 |
105 |
| Aytu Biopharma Inc |
$ 16 |
$ 68 |
$ 2 |
16 |
| Biovie Inc |
$ 16 |
- |
$ -24 |
6 |
| Hookipa Pharma inc |
$ 16 |
$ 9 |
$ -73 |
28 |
| Acer Therapeutics Inc |
$ 16 |
- |
$ -48 |
40 |
| Marker Therapeutics inc |
$ 16 |
$ 6 |
$ -13 |
66 |
| 23andme Holding Co |
$ 16 |
$ 189 |
$ -281 |
582 |
| Synlogic Inc |
$ 16 |
$ 1 |
$ 9 |
35 |
| Leap Therapeutics Inc |
$ 16 |
$ 2 |
$ -69 |
18 |
| Hoth Therapeutics Inc |
$ 15 |
- |
$ -10 |
9 |
| Exicure Inc |
$ 15 |
$ 7 |
$ -10 |
31 |
| Cocrystal Pharma Inc |
$ 15 |
$ 2 |
$ -18 |
11 |
| Cadrenal Therapeutics Inc |
$ 15 |
- |
$ -11 |
10 |
| Mei Pharma Inc |
$ 15 |
$ 42 |
$ -32 |
6 |
| Inhibitor Therapeutics Inc |
$ 14 |
- |
$ -3 |
5 |
| Universe Pharmaceuticals Inc |
$ 14 |
$ 32 |
$ -6 |
100 |
| Bioxytran Inc |
$ 14 |
- |
$ -3 |
- |
| Rallybio Corporation |
$ 14 |
$ 1 |
$ -48 |
- |
| Bullfrog Ai Holdings Inc |
$ 14 |
- |
$ -7 |
- |
| Unity Biotechnology Inc |
$ 14 |
- |
$ -28 |
75 |
| Kiora Pharmaceuticals Inc |
$ 13 |
- |
$ -12 |
44 |
| Cellectar Biosciences Inc |
$ 13 |
- |
$ -25 |
12 |
| Minerva Neurosciences Inc |
$ 13 |
- |
$ 6 |
31 |
| Nextcure Inc |
$ 13 |
- |
$ -50 |
43 |
| Cell Source Inc |
$ 13 |
- |
$ -5 |
11 |
| Therapeuticsmd Inc |
$ 13 |
$ 1 |
$ -3 |
325 |
| Flora Growth Corp |
$ 13 |
$ 35 |
$ -71 |
76 |
| Talphera Inc |
$ 12 |
$ 2 |
$ -12 |
- |
| Prophase Labs Inc |
$ 12 |
$ 10 |
$ -43 |
24 |
| Imunon Inc |
$ 12 |
$ 1 |
$ -19 |
25 |
| Neuphoria Therapeutics Inc |
$ 12 |
- |
$ -23 |
- |
| Equillium Inc |
$ 12 |
$ 41 |
$ -6 |
35 |
| Gelesis Holdings Inc |
$ 12 |
$ 12 |
$ -53 |
64 |
| Geovax Labs Inc |
$ 11 |
$ 6 |
$ -24 |
16 |
| Acurx Pharmaceuticals inc |
$ 11 |
- |
$ -12 |
11 |
| Integrated Biopharma Inc |
$ 11 |
$ 53 |
$ 1 |
50 |
| Shuttle Pharmaceuticals Holdings Inc |
$ 11 |
- |
$ -9 |
14 |
| Applied Molecular Transport Inc |
$ 10 |
- |
$ -75 |
10 |
| Accustem Sciences Inc |
$ 10 |
- |
$ -2 |
- |
| Edesa Biotech Inc |
$ 10 |
- |
$ -6 |
36 |
| Allarity Therapeutics Inc |
$ 10 |
$ 24 |
$ -24 |
14 |
| Agile Therapeutics Inc |
$ 10 |
$ 20 |
$ -16 |
19 |
| Glycomimetics Inc |
$ 10 |
$ 1 |
$ -50 |
51 |
| Aprea Therapeutics Inc |
$ 10 |
- |
$ -14 |
34 |
| Phio Pharmaceuticals Corp |
$ 10 |
- |
$ -7 |
10 |
| Apexigen Inc |
$ 10 |
- |
$ -40 |
- |
| Citius Pharmaceuticals Inc |
$ 9 |
- |
$ -41 |
51 |
| Eyenovia inc |
$ 9 |
$ 0 |
$ -42 |
10 |
| Lucy Scientific Discovery Inc |
$ 9 |
- |
$ -4 |
22 |
| Mustang Bio inc |
$ 9 |
- |
$ -70 |
32 |
| Orgenesis Inc |
$ 8 |
$ 1 |
$ 35 |
146 |
| Briacell Therapeutics Corp |
$ 8 |
- |
$ -22 |
24 |
| Bioxcel Therapeutics Inc |
$ 8 |
$ 2 |
$ -40 |
116 |
| Ibio inc |
$ 8 |
$ 2 |
$ -22 |
14 |
| Cyclerion Therapeutics Inc |
$ 8 |
$ 2 |
$ -3 |
19 |
| Dogwood Therapeutics inc |
$ 7 |
- |
$ -24 |
13 |
| Evoke Pharma Inc |
$ 7 |
$ 12 |
$ -5 |
8 |
| Metavia Inc |
$ 7 |
- |
$ 0 |
- |
| Alaunos Therapeutics Inc |
$ 7 |
- |
$ -4 |
12 |
| Kairos Pharma Ltd |
$ 7 |
- |
$ 0 |
- |
| Elevai Labs Inc |
$ 7 |
- |
$ 0 |
- |
| Aptinyx Inc |
$ 7 |
$ 2 |
$ -66 |
24 |
| Cingulate Inc |
$ 6 |
- |
$ -16 |
15 |
| Gt Biopharma Inc |
$ 6 |
- |
$ -13 |
34 |
| China Pharma Holdings Inc |
$ 6 |
$ 4 |
$ -5 |
231 |
| Cv Sciences Inc |
$ 6 |
$ 14 |
$ -2 |
49 |
| Lftd Partners Inc |
$ 5 |
$ 36 |
$ -1 |
148 |
| Synaptogenix Inc |
$ 5 |
- |
$ 14 |
10 |
| Nucana Plc |
$ 5 |
- |
$ -28 |
18 |
| Spyre Therapeutics Inc |
$ 5 |
$ 6 |
$ -209 |
31 |
| Soligenix inc |
$ 5 |
$ 1 |
$ -10 |
14 |
| Quoin Pharmaceuticals Ltd |
$ 5 |
- |
$ -10 |
- |
| Ainos Inc |
$ 5 |
$ 3 |
$ -15 |
- |
| Matinas Biopharma Holdings Inc |
$ 5 |
$ 4 |
$ -6 |
202 |
| Nabriva Therapeutics Plc |
$ 5 |
$ 30 |
$ -55 |
40 |
| Aptorum Group Limited |
$ 4 |
$ 0 |
$ -4 |
12 |
| Galecto Inc |
$ 4 |
- |
$ -18 |
10 |
| Incannex Healthcare Inc |
$ 4 |
- |
$ -5 |
16 |
| Xenetic Biosciences Inc |
$ 4 |
$ 3 |
$ -4 |
11 |
| Immuron Limited |
$ 4 |
$ 1 |
$ -4 |
12 |
| Guardion Health Sciences Inc |
$ 4 |
$ 9 |
$ 6 |
- |
| Rvl Pharmaceuticals Plc |
$ 4 |
$ 36 |
$ -68 |
- |
| Genprex Inc |
$ 4 |
- |
$ -19 |
15 |
| Sunshine Biopharma Inc |
$ 4 |
$ 36 |
$ -5 |
17 |
| Kineta Inc |
$ 4 |
- |
$ -8 |
50 |
| Emmaus Life Sciences Inc |
$ 4 |
$ 16 |
$ -4 |
35 |
| Atreca inc |
$ 4 |
- |
$ -98 |
75 |
| Lipella Pharmaceuticals Inc |
$ 3 |
$ 1 |
$ -5 |
16 |
| Biofrontera Inc |
$ 3 |
$ 123 |
$ -8 |
93 |
| Scienture Holdings Inc |
$ 3 |
- |
$ 9 |
- |
| Protokinetix Incorporated |
$ 3 |
- |
$ 0 |
- |
| Oncorus Inc |
$ 3 |
- |
$ -91 |
34 |
| Blue Water Vaccines Inc |
$ 3 |
$ 2 |
$ -57 |
11 |
| Azitra Inc |
$ 3 |
- |
$ -9 |
- |
| Actavia Life Sciences Inc |
$ 3 |
$ 0 |
$ 0 |
- |
| Novabay Pharmaceuticals Inc |
$ 3 |
$ 9 |
$ 3 |
31 |
| Spruce Biosciences Inc |
$ 3 |
$ 5 |
$ -55 |
22 |
| 180 Life Sciences Corp |
$ 3 |
- |
$ -7 |
10 |
| Aravive Inc |
$ 3 |
$ 7 |
$ -40 |
31 |
| Aeon Biopharma inc |
$ 3 |
- |
$ 64 |
10 |
| Galera Therapeutics Inc |
$ 3 |
- |
$ -15 |
50 |
| Silo Pharma Inc |
$ 3 |
$ 0 |
$ -5 |
9 |
| Cannapharmarx Inc |
$ 3 |
- |
$ 1 |
- |
| Traws Pharma inc |
$ 3 |
$ 0 |
$ -55 |
- |
| Entero Therapeutics Inc |
$ 3 |
- |
$ -16 |
51 |
| Indaptus Therapeutics Inc |
$ 3 |
- |
$ -15 |
61 |
| Moleculin Biotech Inc |
$ 2 |
- |
$ -23 |
15 |
| Palatin Technologies Inc |
$ 2 |
$ 2 |
$ -23 |
11 |
| Novan Inc |
$ 2 |
$ 25 |
$ -32 |
37 |
| Sonnet Biotherapeutics Holdings Inc |
$ 2 |
$ 0 |
$ -9 |
13 |
| Aditxt Inc |
$ 2 |
$ 0 |
$ -38 |
31 |
| Notable Labs Ltd |
$ 2 |
- |
$ -24 |
- |
| Bellicum Pharmaceuticals Inc |
$ 2 |
$ 1 |
$ 3 |
72 |
| Oncternal Therapeutics Inc |
$ 2 |
$ 2 |
$ -35 |
24 |
| Cns Pharmaceuticals Inc |
$ 2 |
$ 0 |
$ -16 |
15 |
| 60 Degrees Pharmaceuticals Inc |
$ 2 |
- |
$ 0 |
- |
| Conduit Pharmaceuticals Inc |
$ 2 |
- |
$ -18 |
- |
| One World Products Inc |
$ 2 |
$ 0 |
$ -6 |
- |
| Salarius Pharmaceuticals inc |
$ 2 |
$ 5 |
$ -6 |
8 |
| Lixte Biotechnology Holdings Inc |
$ 2 |
- |
$ -4 |
16 |
| Jaguar Health Inc |
$ 2 |
$ 12 |
$ -40 |
69 |
| Galmed Pharmaceuticals Ltd |
$ 2 |
$ 2 |
$ 8 |
40 |
| Tharimmune Inc |
$ 2 |
- |
$ -12 |
- |
| Xortx Therapeutics inc |
$ 2 |
$ 1 |
$ -2 |
8 |
| Vaccinex Inc |
$ 2 |
- |
$ -19 |
71 |
| Pasithea Therapeutics Corp |
$ 2 |
$ 0 |
$ -14 |
24 |
| Dmk Pharmaceuticals Corporation |
$ 2 |
$ 4 |
$ -22 |
- |
| Adial Pharmaceuticals Inc |
$ 2 |
- |
$ -9 |
10 |
| Vbi Vaccines Inc |
$ 1 |
$ 9 |
$ -84 |
31 |
| Ensysce Biosciences Inc |
$ 1 |
$ 5 |
$ -8 |
9 |
| Axim Biotechnologies Inc |
$ 1 |
$ 0 |
$ -4 |
45 |
| Bio path Holdings inc |
$ 1 |
- |
$ -10 |
9 |
| Cohbar Inc |
$ 1 |
- |
$ -13 |
- |
| Aptevo Therapeutics Inc |
$ 1 |
$ 13 |
$ -24 |
37 |
| Panbela Therapeutics Inc |
$ 1 |
- |
$ -28 |
26 |
| Avenir Wellness Solutions Inc |
$ 1 |
$ 3 |
$ -3 |
- |
| Bespoke Extracts Inc |
$ 1 |
$ 1 |
$ -1 |
- |
| Virpax Pharmaceuticals Inc |
$ 1 |
- |
$ -12 |
5 |
| Timber Pharmaceuticals Inc |
$ 1 |
$ 1 |
$ -15 |
10 |
| Neubase Therapeutics inc |
$ 1 |
- |
$ -14 |
7 |
| Dermata Therapeutics Inc |
$ 1 |
- |
$ -12 |
11 |
| International Stem Cell Corporation |
$ 1 |
$ 9 |
$ 0 |
8 |
| 9 Meters Biopharma Inc |
$ 1 |
- |
$ -46 |
30 |
| Processa Pharmaceuticals Inc |
$ 1 |
- |
$ -12 |
12 |
| Impel Pharmaceuticals Inc |
$ 1 |
$ 8 |
$ -74 |
89 |
| Histogen Inc |
$ 1 |
$ 0 |
$ -12 |
16 |
| Skinvisible Inc |
$ 1 |
$ 0 |
$ -1 |
14 |
| Syros Pharmaceuticals Inc |
$ 1 |
$ 23 |
$ -98 |
47 |
| Trevena inc |
$ 1 |
$ 0 |
$ -34 |
71 |
| Neptune Wellness Solutions Inc |
$ 1 |
$ 39 |
$ -75 |
85 |
| Biostax Corp |
$ 1 |
- |
$ -2 |
- |
| Painreform Ltd |
$ 1 |
- |
$ -15 |
- |
| Evofem Biosciences Inc |
$ 1 |
$ 19 |
$ -9 |
32 |
| Revelation Biosciences Inc |
$ 1 |
- |
$ -14 |
8 |
| Infinity Pharmaceuticals Inc |
$ 1 |
$ 3 |
$ -41 |
41 |
| Zyversa Therapeutics Inc |
$ 1 |
- |
$ -9 |
- |
| Gri Bio Inc |
$ 1 |
- |
$ -9 |
- |
| Theratechnologies Inc |
$ 1 |
$ 82 |
$ -24 |
88 |
| Enveric Biosciences Inc |
$ 1 |
- |
$ -10 |
12 |
| Bioadaptives Inc |
$ 1 |
$ 0 |
$ -1 |
- |
| Avenue Therapeutics Inc |
$ 1 |
- |
$ -14 |
11 |
| Viracta Therapeutics Inc |
$ 1 |
- |
$ -43 |
12 |
| Contrafect Corporation |
$ 1 |
- |
$ -24 |
79 |
| Rebus Holdings Inc |
$ 0 |
- |
$ 1 |
- |
| Nexien Biopharma Inc |
$ 0 |
- |
$ 0 |
13 |
| Northwest Biotherapeutics Inc |
$ 0 |
$ 1 |
$ -86 |
25 |
| Athersys Inc |
$ 0 |
$ 5 |
$ -83 |
43 |
| Sangui Biotech International Inc |
$ 0 |
$ 0 |
$ 0 |
10 |
| Lannett Company Inc |
$ 0 |
$ 289 |
$ -274 |
116 |
| Theriva Biologics inc |
$ 0 |
- |
$ -19 |
22 |
| Clearmind Medicine Inc |
$ 0 |
- |
$ 0 |
1 |
| The Greater Cannabis Company Inc |
$ 0 |
- |
$ 0 |
- |
| Tff Pharmaceuticals Inc |
$ 0 |
$ 1 |
$ -18 |
25 |
| Petros Pharmaceuticals inc |
$ 0 |
$ 4 |
$ -23 |
- |
| Respirerx Pharmaceuticals Inc |
$ 0 |
- |
$ -3 |
- |
| Globestar Therapeutics Corporation |
$ 0 |
- |
$ -1 |
- |
| Ocean Biomedical Inc |
$ 0 |
- |
$ -27 |
22 |
| Reshape Lifesciences Inc |
$ 0 |
$ 6 |
$ -3 |
65 |
| Regen Biopharma Inc |
$ 0 |
$ 0 |
$ -1 |
3 |
| Vincerx Pharma Inc |
$ 0 |
- |
$ -23 |
12 |
| Regenerx Biopharmaceuticals inc |
$ 0 |
$ 0 |
$ -2 |
6 |
| Baudax Bio Inc |
$ 0 |
$ 1 |
$ -7 |
16 |
| Bellerophon Therapeutics inc |
$ 0 |
- |
$ -9 |
45 |
| Humanigen Inc |
$ 0 |
$ 2 |
$ -54 |
34 |
| Endo International Plc |
$ 0 |
$ 2,012 |
$ -2,450 |
2,931 |
| Nascent Biotech Inc |
$ 0 |
$ 0 |
$ -2 |
8 |
| Scorpius Holdings inc |
$ 0 |
$ 6 |
$ -34 |
- |
| Biora Therapeutics Inc |
$ 0 |
$ 0 |
$ -32 |
17 |
| Inmed Pharmaceuticals Inc |
$ 0 |
$ 7 |
$ -3 |
11 |
| Seelos Therapeutics inc |
$ 0 |
$ 2 |
$ 4 |
16 |
| Qualigen Therapeutics Inc |
$ 0 |
$ 5 |
$ -9 |
49 |
| Novaccess Global Inc |
$ 0 |
- |
$ -2 |
- |
| Vaxxinity Inc |
$ 0 |
- |
$ -75 |
54 |
| Scopus Biopharma Inc |
$ 0 |
- |
$ -9 |
20 |
| Q Biomed inc |
$ 0 |
$ 0 |
$ -1 |
11 |
| Procyon Corporation |
$ 0 |
$ 5 |
$ 0 |
- |
| Adhera Therapeutics Inc |
$ 0 |
$ 2,732 |
$ -3 |
30 |
| Hepion Pharmaceuticals Inc |
$ 0 |
- |
$ -13 |
20 |
| Evelo Biosciences Inc |
$ 0 |
- |
$ -82 |
30 |
| Mallinckrodt Plc |
$ 0 |
$ 1,906 |
$ -163 |
2,700 |
| American Bio Medica Corporation |
$ 0 |
$ 1 |
$ 1 |
10 |
| Comera Life Sciences Holdings Inc |
$ 0 |
$ 1 |
$ -12 |
28 |
| Ampio Pharmaceuticals inc |
$ 0 |
$ 0 |
$ -9 |
7 |
| Effector Therapeutics Inc |
$ 0 |
- |
$ -35 |
47 |
| Paxmedica Inc |
$ 0 |
- |
$ -18 |
10 |
| Molecular Templates Inc |
$ 0 |
$ 60 |
$ -48 |
62 |
| Clever Leaves Holdings Inc |
$ 0 |
$ 17 |
$ -18 |
500 |
| Ovid Therapeutics Inc |
$ 0 |
$ 1 |
$ -25 |
60 |
| Neximmune Inc |
$ 0 |
- |
$ -21 |
40 |
| Apollomics Inc |
- |
- |
$ 0 |
20 |
| Alterity Therapeutics Limited |
- |
- |
$ 0 |
48 |
| Biodexa Pharmaceuticals Plc |
- |
$ 0 |
$ -7 |
37 |
| Cnbx Pharmaceuticals Inc |
- |
$ 1 |
$ 0 |
11 |
| Innovation Pharmaceuticals Inc |
- |
- |
$ -3 |
11 |
| Cyclacel Pharmaceuticals Inc |
- |
$ 0 |
$ -11 |
62 |
| Altamira Therapeutics Ltd |
- |
$ 0 |
$ -27 |
32 |
| Grifols Sa |
- |
- |
$ 202 |
24,000 |
| Quantum Biopharma Ltd |
- |
$ 5 |
$ -14 |
19 |
| Medicure Inc |
- |
$ 17 |
$ -1 |
50 |
| Innovation1 Biotech Inc |
- |
$ 0 |
$ -5 |
- |
| Neurosense Therapeutics Ltd |
- |
- |
$ 0 |
11 |
| Propanc Biopharma Inc |
- |
- |
$ -2 |
10 |
| Proqr Therapeutics N v |
- |
- |
$ 0 |
48 |
| Avricore Health Inc |
- |
$ 2 |
$ -1 |
12 |
| Kaya Holdings Inc |
- |
$ 1 |
$ -3 |
17 |
| Affimed N v |
- |
$ 9 |
$ -119 |
102 |
| Denali Capital Acquisition Corp |
- |
- |
$ 0 |
- |
| Telomir Pharmaceuticals Inc |
- |
- |
$ -17 |
- |
| Total Major Pharmaceutical Preparations Industry |
$ 3,910,693 |
$ 757,021 |
$ 73,447 |
1,235,994 |
Recent News from The Largest Companies in Major Pharmaceutical Preparations Industry |
|
Clinical Study
'Advancement in Hypoparathyroidism Treatment: MBX Biosciences? Phase 2 Avail Trial of MBX 2109 Concludes Enrollment'MBX Biosciences has reached a significant milestone in the development of its promising treatment for hypoparathyroidism with the completion of participant enrollment in the Phase 2 Avail trial for MBX 2109, also known as Canvuparatide. With...
|
|
|
Announcement
' for CSIMarket.com 'On March 3, 2025, Allarity Therapeutics, Inc. (NASDAQ: ALLR), a clinical-stage pharmaceutical company focused on developing personalized cancer therapies, announced an authorization from its Board of Directors for a share repurchase program amounting to $5 million. This program is to be executed through February 28, 2026, as part of...
|
|
|
Announcement
'Abstract:'Chemomab Therapeutics Ltd. recently announced its financial results for the fourth quarter and the year ended 2024, revealing mixed outcomes regarding its performance relative to competitors in the pharmaceutical sector. While the company reported promising results from its Phase 2 trial for nebokitug in primary sclerosing cholangitis, its fina...
|
|
|
Announcement
'Abstract:' Enlivex Therapeutics Ltd. has reported compelling interim results from its Phase I clinical trial of Allocetra, an innovative macrophage reprogramming immunotherapy. This article examines the data from the study, which focuses on the treatment of moderate to severe knee osteoarthritis and highlights the significance of the findings in the con...
|
|
|
Business Update
Zai Lab Limited, a burgeoning pharmaceutical company with listings on NASDAQ (ZLAB) and the Hong Kong Stock Exchange (9688), is set to enhance its visibility and investor engagement through participation in key investor conferences in March 2025. With events like the Leerink Partners 2025 Global Healthcare Conference and the Jefferies Biotech on the Beach...
|
|
|
Business Update
KalVista Pharmaceuticals Unveils New Sebetralstat Data at AAAAI WAO 2025 Joint Congress: Promising Advances in Treating Hereditary Angioedema'CAMBRIDGE, Mass. and SALISBURY, England' ?? KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced its commitment to advancing the field of hereditary angioedema (HAE) treatment with the presentation of novel ...
|
|
|
Business Update
'Adicet Bio Pioneers Allogeneic Gamma Delta T Cell Therapies as It Prepares to Showcase Breakthrough Findings at SITC 2025'In a transformative era for cancer therapy and autoimmune disease treatment, Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company specializing in allogeneic gamma delta T cell therapies, continues to set the pace in...
|
|
|
Clinical Study
In the constantly shifting landscape of pharmaceutical research, Pliant Therapeutics, Inc., based in South San Francisco, has recently made significant strides, only to find themselves pausing for reassessment. The company announced that it has discontinued its BEACON-IPF Phase 2b trial, which was evaluating the efficacy of bexotegrast in patients sufferi...
|
|
|
Business Update
Acadia Pharmaceuticals Inc. has recently shared promising updates regarding its clinical drug candidates and corporate strategies, underscoring the company?s commitment to developing therapies for central nervous system (CNS) disorders and rare diseases. This article interprets three key announcements and assesses their implications for Acadia's market po...
|
|
|
Product Service News
'Innovative Expansion: LifeVantage Propels Growth with LV360 Launch, Evolve Compensation Enhancements, and AXIO Lemonade Now Available Permanently'LifeVantage Corporation, a global leader in biohacking and nutrigenomics, continues to forge new pathways to success for its independent consultants and loyal consumers across its Asian markets. The company rec...
|
|
|
Product Service News
ANI Pharmaceuticals Receives FDA Approval for Purified Cortrophin Gel Prefilled Syringe Amidst Strong Revenue GrowthIn a significant stride within the biopharmaceutical landscape, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) recently announced the approval of its new presentation of Purified Cortrophin Gel (repository corticotropin injection USP) in a prefil...
|
|
|
Business Update
The landscape of oncology treatment continues to evolve as the U.S. Food and Drug Administration (FDA) recently approved TEVIMBRA (tislelizumab-jsgr), a monoclonal antibody, for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC). This groundbreaking decision marks a significant advancement in the t...
|
|
|
Clinical Study
In a noteworthy presentation at the 7th International Congress on Controversies in Fibromyalgia, Tonix Pharmaceuticals showcased groundbreaking data regarding its innovative therapeutic agent, TNX-102 SL. This sublingual formulation of cyclobenzaprine, designed for effective transmucosal delivery, holds the potential for durable therapeutic activity in th...
|
|
|
Clinical Study
Capricor Therapeutics Advances Toward a Milestone in Duchenne Muscular Dystrophy Treatment with FDA Priority ReviewCapricor Therapeutics has taken a significant step forward in the field of genetic medicine, announcing that the U.S. Food and Drug Administration (FDA) has not only accepted but also granted priority review status to their Biologics License...
|
|
|
Clinical Study
Quoin Pharmaceuticals: Advancing Rare Disease Treatment Frontiers with Novel Rapamycin Formulations and Positive Netherton Syndrome Study OutcomesASHBURN, Va.??In a determined stride towards addressing unmet medical needs in the realm of rare and orphan diseases, Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company...
|
|
|
Business Update
'KalVista Pharmaceuticals Announces Strategic Expansion with Key Inducement Grants'KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent name in the biopharmaceutical industry, recently fortified its team by granting inducement options to two newly-hired employees, in alignment with the company's growth trajectory. On March 3, 2025, the compensation ...
|
|
|
Clinical Study
The landscape of drug development for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) is fraught with challenges, yet it is also imbued with the potential for groundbreaking advancements. On March 4, 2025, Tiziana Life Sciences, Ltd., a biotechnology company focused on innovative immunomodulation therapies, took a decisive step forw...
|
|
|
Clinical Study
In a significant stride towards improving the treatment landscape for non-small cell lung cancer (NSCLC), Nuvectis Pharma has announced the publication of a research study conducted at the Lerner Research Institute, part of the Cleveland Clinic at Case Western Reserve University. The study highlights the potential of the combination of NXP900 and epiderma...
|
|
|
Product Service News
'FibroBiologics Pioneers Mitochondrial Modulation: A New Horizon in Chronic Condition Therapeutics'In the continuously evolving landscape of pharmaceutical science, innovation stands as the keystone to future medical breakthroughs. FibroBiologics Inc., a pioneering force in the industry, has recently taken a monumental step by filing a patent for a ground...
|
|
|
Product Service News
On June 13, 2025, Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology firm focused on pioneering therapeutics for cancer treatment, announced a significant corporate action: a 1-for-20 reverse stock split of its issued and outstanding shares of common stock. This move, set to take effect at 5:00 p.m. Eastern Time on June 16, 2025, ...
|
|
|
Business Update
AbstractThe recent approvals of KEYTRUDA (pembrolizumab) signify a substantial advancement in the treatment landscape for head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC). Merck's collaborations further bolster its commitment to innovating therapeutic interventions across multiple oncological pathways. This article out...
|
|
|
Business Update
'Unlocking New Horizons in Hematology: Breakthroughs by BeOne Medicines and BeiGene'San Carlos, California ?? In a major stride within the oncology sector, BeOne Medicines Ltd. (traded on NASDAQ: ONC, HKEX: 06160, SSE: 688235) has unveiled groundbreaking clinical data at the European Hematology Association (EHA) 2025 Congress. This move underscores BeOne'...
|
|
|
Clinical Study
'Abstract:' The 2025 European Hematology Association (EHA) conference highlighted a pivotal advancement in acute leukemia treatment, specifically targeting patients with FLT3-mutant acute myeloid leukemia (AML). Biomea Fusion presented updated preliminary clinical data concerning their novel therapeutic agent, BMF-500, a covalent FLT3 inhibitor. This repo...
|
|
|
Partnership
'Abstract'In an era where the pharmaceutical landscape is rapidly evolving, the integration of artificial intelligence (AI) and machine learning into drug development processes has emerged as a pivotal factor in enhancing efficiency and outcomes. This article discusses the groundbreaking strategic collaboration between BullFrog AI and Sygnature Discovery,...
|
|
|
Clinical Study
'Abstract' Third Harmonic Bio Inc. (THB) has recently undergone significant corporate transformations, including stockholder-approved liquidation and dissolution. Meanwhile, financial ratios reveal a dynamic yet challenging fiscal environment. This article explores the implications of these developments for the company and its stakeholders, providing ins...
|
|
|
Business Update
In a groundbreaking development for oncology therapeutics, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235) announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of BRUKINSA (zanubrutinib) for all five previously sanctioned indications. Originally introduced to combat chronic lymphocytic leukemia (CLL...
|
|
|
Announcement
Allarity Therapeutics, Inc. (NASDAQ: ALLR), a pharmaceutical company focused on advancing personalized cancer therapies, has announced a significant change in its Board of Directors. Effective June 30, 2025, Jesper Hiland will be appointed to the board, taking the position previously held by Joseph Vazzano, who will step down after serving for two years.A...
|
|
|
Announcement
'Organon Shareholder Alert: Investors Urged to Act Amid Class Action Lawsuit Due to Underperformance'In a noteworthy development for shareholders of Organon and Co. (NYSE: OGN), ClaimsFiler has issued a reminder to investors who have suffered losses exceeding $100,000 to file lead plaintiff applications in an ongoing class action lawsuit. The deadline for...
|
|
|
Announcement
' for CSIMarket.com ''PepGen Inc.: Navigating a Strategic Pivot Amidst Legal and Market Challenges'PepGen Inc. (NASDAQ: PEPG), a biopharmaceutical company, currently finds itself at a crucial juncture. Recently, the law firm Bragar Eagel and Squire, P.C. announced a class action lawsuit against the company, urging investors to contact them for possible c...
|
|
|
Clinical Study
Capricor Therapeutics, a biotechnology company focused on developing innovative cell and exosome-based therapeutics for rare diseases, has announced significant regulatory progress for its Duchenne Muscular Dystrophy (DMD) program. The company reported the successful completion of a Pre-License Inspection (PLI) of its manufacturing facility located in San...
|
|
|
|
|
|
